Johanna Buchroithner

1.3k total citations
13 papers, 451 citations indexed

About

Johanna Buchroithner is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Johanna Buchroithner has authored 13 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Johanna Buchroithner's work include Glioma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Johanna Buchroithner is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Johanna Buchroithner collaborates with scholars based in Austria, Germany and United States. Johanna Buchroithner's co-authors include Walter Berger, M. Micksche, Sabine Spiegl‐Kreinecker, Johannes Fischer, Leonilla Elbling, Christine Pirker, Christine Marosi, Josef Pichler, René Silye and Elisabeth Steiner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Johanna Buchroithner

13 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johanna Buchroithner Austria	8	222	192	146	123	66	13	451
Jethro Hu United States	13	139 0.6×	295 1.5×	93 0.6×	112 0.9×	56 0.8×	34	471
Jeffery J. Raizer United States	8	222 1.0×	259 1.3×	177 1.2×	114 0.9×	42 0.6×	11	545
Alfred Yung United States	16	279 1.3×	370 1.9×	167 1.1×	150 1.2×	33 0.5×	29	672
Mohamad A. Salkeni United States	11	317 1.4×	76 0.4×	237 1.6×	140 1.1×	69 1.0×	42	603
Karel Zitterbart Czechia	14	291 1.3×	84 0.4×	198 1.4×	103 0.8×	25 0.4×	33	486
Perrine Dahan France	8	400 1.8×	161 0.8×	132 0.9×	162 1.3×	46 0.7×	8	594
Sandra H. E. Sprenger Netherlands	12	257 1.2×	239 1.2×	93 0.6×	205 1.7×	25 0.4×	13	538
Yoshinari Shinsato Japan	14	284 1.3×	75 0.4×	164 1.1×	129 1.0×	40 0.6×	20	523
Kirsi J. Granberg Finland	12	255 1.1×	123 0.6×	68 0.5×	111 0.9×	48 0.7×	18	386
Cláudia C. Faria Portugal	13	206 0.9×	175 0.9×	60 0.4×	81 0.7×	18 0.3×	42	429

Countries citing papers authored by Johanna Buchroithner

Since Specialization

Citations

This map shows the geographic impact of Johanna Buchroithner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Buchroithner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Buchroithner more than expected).

Fields of papers citing papers by Johanna Buchroithner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Buchroithner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Buchroithner. The network helps show where Johanna Buchroithner may publish in the future.

Co-authorship network of co-authors of Johanna Buchroithner

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Buchroithner. A scholar is included among the top collaborators of Johanna Buchroithner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Buchroithner. Johanna Buchroithner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Galijašević, Malik, Stephanie Mangesius, Hans H. Goebel, et al.. (2022). MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. Cancers. 14(6). 1579–1579. 7 indexed citations

Erhart, Friedrich, Johanna Buchroithner, Katrin Fischhuber, et al.. (2018). Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. Acta Neuropathologica Communications. 6(1). 135–135. 43 indexed citations

Felzmann, Thomas, Johanna Buchroithner, Christine Marosi, et al.. (2014). A randomized clinical trial for the treatment of glioblastoma multiforme with the individualized dendritic cell-based cancer immunotherapy AV0113.. Journal of Clinical Oncology. 32(15_suppl). 2052–2052. 1 indexed citations

Hutterer, Markus, Martha Nowosielski, Johannes Haybaeck, et al.. (2013). A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology. 16(1). 92–102. 62 indexed citations

Felzmann, Thomas, Johanna Buchroithner, Christine Marosi, et al.. (2013). Abstract 4658: First interim analysis of a randomized study to evaluate safety and efficacy of individualized dendritic cell-based cancer immune therapy for glioblastoma multiforme.. Cancer Research. 73(8_Supplement). 4658–4658. 1 indexed citations

Buchroithner, Johanna, Josef Pichler, Christine Marosi, et al.. (2013). Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy. International Journal of Clinical Pharmacology and Therapeutics. 52(1). 76–77. 15 indexed citations

Buchroithner, Johanna, et al.. (2012). AIRP Best Cases in Radiologic-Pathologic Correlation: Human Coenurosis (TaeniaLarva). Radiographics. 32(2). 517–521. 7 indexed citations

Spiegl‐Kreinecker, Sabine, Christine Pirker, Martin Filipits, et al.. (2009). O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. Neuro-Oncology. 12(1). 28–36. 67 indexed citations

Fischer, Hendrik, Sabine Spiegl‐Kreinecker, Christine Gauglhofer, et al.. (2008). FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene. 27(30). 4180–4190. 84 indexed citations

10.

Lanmüller, Hermann, Johanna Buchroithner, J. Wernisch, & François Alesch. (2007). Sudden failure of implantable pulse generators: cause of failure and examination / Plötzlicher Ausfall von implantierbaren Stimulatoren: Ausfallsursache und Überprüfung. Biomedizinische Technik/Biomedical Engineering. 52(5). 356–359. 1 indexed citations

11.

Spiegl‐Kreinecker, Sabine, Christine Pirker, Christine Marosi, et al.. (2007). Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma. British Journal of Cancer. 96(6). 960–969. 29 indexed citations

12.

Spiegl‐Kreinecker, Sabine, Johanna Buchroithner, Leonilla Elbling, et al.. (2002). Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes. Journal of Neuro-Oncology. 57(1). 27–36. 81 indexed citations

13.

Berger, Walter, Sabine Spiegl‐Kreinecker, Johanna Buchroithner, et al.. (2001). Overexpression of the human major vault protein in astrocytic brain tumor cells. International Journal of Cancer. 94(3). 377–382. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact